Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Bangkok Lab and Cosmetic PCL Days Payable?
Bangkok Lab and Cosmetic PCLBKK:BLC +0.51%63 Days Payable is 101.74 as of Jun. 2026, which is 38% above its 10-year median of 73.62. GuruFocus rates BKK:BLC with a GF Score™ of 63/100 and a GF Value™ of ฿4.74 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,894 Consumer Packaged Goods companies, Bangkok Lab and Cosmetic PCL ranks better than 78.78% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Bangkok Lab and Cosmetic PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Lab and Cosmetic PCL Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bangkok Lab and Cosmetic PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Bangkok Lab and Cosmetic PCL's Days Payable falls into.
Bangkok Lab and Cosmetic PCL Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Lab and Cosmetic PCL (BKK:BLC) has a Days Payable of 101.74 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. This is 38% above median its historical median of 73.62. Over the past decade, Bangkok Lab and Cosmetic PCL's Days Payable has ranged from 62.30 to 87.84. According to the industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #402 out of 1894 companies in the Consumer Packaged Goods industry, placing it in the top 21.2%.
Is Bangkok Lab and Cosmetic PCL's Days Payable too high?
Bangkok Lab and Cosmetic PCL's current Days Payable of 101.74 is 38% above median its 10-year median of 73.62. Over the past 10 years, this metric has ranged from a low of 62.30 to a high of 87.84. The Consumer Packaged Goods industry median Days Payable is 44.00. Bangkok Lab and Cosmetic PCL's value of 101.74 is 131.2% above this industry median. Based on the distribution chart, Bangkok Lab and Cosmetic PCL ranks #402 out of 1894 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Lab and Cosmetic PCL has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Lab and Cosmetic PCL's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #402 out of 1894 companies for Days Payable. This places Bangkok Lab and Cosmetic PCL in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.00. Bangkok Lab and Cosmetic PCL's value of 101.74 is 131.2% above this benchmark. Historically, Bangkok Lab and Cosmetic PCL's own Days Payable has ranged from 62.30 to 87.84 over the past decade. While the company's 10-year median is 73.62 vs. the industry median of 44.00, Bangkok Lab and Cosmetic PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.00, based on 1,894 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Lab and Cosmetic PCL's current Days Payable of 101.74 is 131.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Lab and Cosmetic PCL's current Days Payable is 101.74, which is 38% above median its own 10-year median of 73.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Lab and Cosmetic PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL (BKK:BLC) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿4.74, compared to a current price of ฿3.92 — trading 17.3% below its estimated fair value. The current Days Payable is 101.74, which is 38% above median its 10-year median of 73.62 and 131.2% above the Consumer Packaged Goods industry median of 44.00. Bangkok Lab and Cosmetic PCL's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bangkok Lab and Cosmetic PCL (BKK:BLC), the current Days Payable is 101.74 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Lab and Cosmetic PCL (BKK:BLC) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL stock appears to be undervalued.
The current stock price of ฿3.92 is trading 17.3% below its estimated GF Value™ of ฿4.74.
GuruFocus considers Bangkok Lab and Cosmetic PCL to be Modestly Undervalued.
Key valuation signals for BKK:BLC:
Days Payable: 101.74 (38% above median its 10-year median of 73.62)
GF Value™: ฿4.74 vs. price of ฿3.92 (17.3% below fair value)
Industry Position: 131.2% above the Consumer Packaged Goods median (#402 of 1894)
No single metric tells the full story. See the BKK:BLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. The principal activities of the Group are the manufacturing and distributing of pharmaceuticals and medicinal chemical products for human and animal It operates in a single line of business, namely pharmaceuticals and medicinal chemical products, The Group derives revenue from sales of goods and rendering of services.
63GF Score
Get the complete analysis for BKK:BLC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BLC has been successfully added to your 
